276 related articles for article (PubMed ID: 6241847)
1. In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
Neu HC; Chin NX; Labthavikul P; Saha G
Chemioterapia; 1984 Aug; 3(4):235-41. PubMed ID: 6241847
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim.
Neu HC; Labthavikul P
Antimicrob Agents Chemother; 1982 Jul; 22(1):23-7. PubMed ID: 6214995
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
[TBL] [Abstract][Full Text] [Related]
4. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
Piccolomini R; Allocati N; Catamo G
Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
[TBL] [Abstract][Full Text] [Related]
5. Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates.
Piccolomini R; Ravagnan G
Chemioterapia; 1986 Aug; 5(4):249-56. PubMed ID: 3769047
[TBL] [Abstract][Full Text] [Related]
6. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Ismaeel NA; Tayeb OS
Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activity of three new quinolone derivatives: rosoxacin, norfloxacin, pefloxacin.
Husson MO; Izard D; Leclerc H
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):283-6. PubMed ID: 6241772
[TBL] [Abstract][Full Text] [Related]
9. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
Clarke AM; Zemcov SJ; Campbell ME
J Antimicrob Chemother; 1985 Jan; 15(1):39-44. PubMed ID: 3156112
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
Periti P; Mazzei T; Nicoletti P
Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents.
Body BA; Fromtling RA; Shadomy S; Shadomy HJ
Eur J Clin Microbiol; 1983 Jun; 2(3):230-4. PubMed ID: 6224678
[TBL] [Abstract][Full Text] [Related]
13. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
Joly-Guillou ML; Bergogne-Berezin E
Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
[TBL] [Abstract][Full Text] [Related]
14. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
Rahal K
Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
[TBL] [Abstract][Full Text] [Related]
15. In vitro effect of pH and glucose concentration on the antibacterial activity of norfloxacin in urine.
Fromtling RA; Abruzzo GK; Gadebusch HH
Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):737-41. PubMed ID: 6241649
[TBL] [Abstract][Full Text] [Related]
16. Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults.
Salmon SA; Watts JL
Avian Dis; 2000; 44(1):85-98. PubMed ID: 10737648
[TBL] [Abstract][Full Text] [Related]
17. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Croize J; Le Noc P; Bryskier A; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of pefloxacin compared to other antibiotics.
Yourassowsky E; Van der Linden MP; Crokaert F; Glupczynski Y
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():19-28. PubMed ID: 3086279
[TBL] [Abstract][Full Text] [Related]
19. [Comparative in vitro antistaphylococcal effect of norfloxacin and pefloxacin on 312 hospital strains].
Ronco E; Pilliot J
Pathol Biol (Paris); 1985 May; 33(5):381-4. PubMed ID: 3162139
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of newer quinolones against aerobic bacteria.
Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
